×

Product Overview

NOW AVAILABLE: A More Objective and Comprehensive Diagnostic Testing Solution
for Difficult-to-Diagnose Melanocytic Lesions. LEARN MORE

Castle Now Offers myPath® Melanoma and
DiffDx™-Melanoma to Provide a Comprehensive Diagnostic Workflow Leveraging the Strengths of Both Products for Better Patient Care

myPath Melanoma has over 35,000 clinically resulted cases and 9 publications including validation to outcomes. DiffDx offers a neural network, artificial intelligence-designed algorithm with a low rate of intermediate results. As we continue to build the evidence for DiffDx, we will offer initial testing with myPath Melanoma. In cases of an intermediate result from the myPath test, we will now add value by performing subsequent testing with DiffDx-Melanoma to provide additional clarity.

melhcp-mypath1.svg
myPath

myPath Melanoma was validated in cutaneous melanocytic lesions to accurately differentiate between benign and malignant melanocytic lesions of unknown potential, based on the expression of 23 genes using standard quantitative qRT-PCR that provides an accurate and objective classification suggestive of benign, intermediate, or malignant.

myPath Melanoma has demonstrated reproducible results across 9 publications including validation to dermatopathology experts' diagnoses and outcomes.

DecisionDx_DiffDx-Melanoma_NoReg_Stack_RGB

The DecisionDx DiffDx-Melanoma test was validated in cutaneous melanocytic lesions to accurately differentiate between benign and malignant melanocytic lesions of unknown potential based on the expression of 35 genes using standard quantitative qRT-PCR that provides an accurate classification suggestive of benign, intermediate, or malignant.

DiffDx-Melanoma has demonstrated high levels of both sensitivity and specificity with a low rate of intermediate results across a wide range of melanocytic subtypes and high rate of technical success.

melhcp-riskidentified.svg

Order Our Comprehensive Diagnostic Offering

For Information

Call: 866-788-9007

Expert Opinions in Melanoma

When Is the myPath Melanoma Test Most Helpful

On-Demand
Educational Programs

What's Next?

myPath Melanoma
Clinical Evidence

How Do You Order a
myPath Melanoma and
DiffDx-Melanoma Test?

Scroll to Top